GRAIL Inc. (GRAL) vs Kodiak Sciences Inc. (KOD)
A side-by-side comparison of GRAIL Inc. and Kodiak Sciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GRAL
GRAIL Inc.
$139.76HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
KOD
Kodiak Sciences Inc.
$92.62HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — GRAL vs KOD
growth of $100 · dividends reinvested · last 2yGRAL +1028.0% (+235.9%/yr)KOD +3274.5% (+480.9%/yr)KOD compounded faster over this window
GRAL KOD
GRAL vs KOD: by the numbers
- •GRAL is the larger company ($6.00B vs $5.80B market cap).
- •Both run net losses; KOD's is the smaller (0.00% vs -236.95% net margin).
Metrics side by side
Valuation
| Metric | GRAL | KOD |
|---|---|---|
| P/S ratio | 36.29 | N/A |
| P/B ratio | 2.36 | 94.87 |
Profitability
| Metric | GRAL | KOD |
|---|---|---|
| Gross margin | -42.52% | 0.00% |
| Operating margin | -362.95% | 0.00% |
| Net margin | -236.95% | 0.00% |
| ROE | -15.40% | -396.09% |
| ROIC | -20.26% | -115.23% |
Growth (annualized)
| Metric | GRAL | KOD |
|---|---|---|
| Total return CAGR (5Y) | N/A | 36.19% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.